Updates on MET Targeted Therapy for EXON 14 Mutations in Lung Cancer | Oncotarget скачать в хорошем качестве

Updates on MET Targeted Therapy for EXON 14 Mutations in Lung Cancer | Oncotarget

Oncotarget #published this #editorial on May 26, 2023 in Volume 14, entitled, “Latest updates on MET targeted therapy for EXON 14 mutations in lung cancer” by Mira Al Jaberi, Wolfgang Clough and Samir Dalia from the Department of Medical Oncology, Mercy Hospital, Joplin, MO. ‪@theMercyChannel‬ #cancer #lungcancer #targetedtherapy #precisionmedicine #openaccess #openscience #peerreview #cancerresearch #research #journal #publication #meded #publishing DOI - https://doi.org/10.18632/oncotarget.28419 Correspondence to - Samir Dalia - [email protected] Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/e... Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/ Keywords - cancer, non small cell lung cancer, MET mutation, targeted therapy, precision medicine About Oncotarget Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science. To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: SoundCloud - https://soundcloud.com/oncotarget Facebook - https://www.facebook.com/Oncotarget/ Twitter - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube -    / @oncotargetjournal   LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Media Contact [email protected] 18009220957